U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    ETFDH electron transfer flavoprotein dehydrogenase [ Homo sapiens (human) ]

    Gene ID: 2110, updated on 27-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    ETFDH mutation involves excessive apoptosis and neurite outgrowth defect via Bcl2 pathway.

    ETFDH mutation involves excessive apoptosis and neurite outgrowth defect via Bcl2 pathway.
    Lin CY, Liang WC, Yu YC, Chang SC, Lai MC, Jong YJ., Free PMC Article

    10/31/2024
    Multiple acyl-CoA dehydrogenase deficiency kills Mycobacterium tuberculosis in vitro and during infection.

    Multiple acyl-CoA dehydrogenase deficiency kills Mycobacterium tuberculosis in vitro and during infection.
    Beites T, Jansen RS, Wang R, Jinich A, Rhee KY, Schnappinger D, Ehrt S., Free PMC Article

    12/18/2021
    Screening of multiple acyl-CoA dehydrogenase deficiency in newborns and follow-up of patients.

    Screening of multiple acyl-CoA dehydrogenase deficiency in newborns and follow-up of patients.
    Zhou D, Ye M, Hu Z, Zhang Y, Zhu L, Yang R, Huang X., Free PMC Article

    11/6/2021
    ETF dehydrogenase advances in molecular genetics and impact on treatment.

    ETF dehydrogenase advances in molecular genetics and impact on treatment.
    Missaglia S, Tavian D, Angelini C.

    10/2/2021
    Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2.

    Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2.
    Xiao C, Astiazaran-Symonds E, Basu S, Kisling M, Scaglia F, Chapman KA, Wang Y, Vockley J, Ferreira CR., Free PMC Article

    06/5/2021
    Clinical characteristics and gene mutation analysis of an adult patient with ETFDHrelated multiple acylCoA dehydrogenase deficiency.

    Clinical characteristics and gene mutation analysis of an adult patient with ETFDH‑related multiple acyl‑CoA dehydrogenase deficiency.
    Wang C, Lv H, Xu X, Ma Y, Li Q., Free PMC Article

    05/1/2021
    Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.

    Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.
    Henriques BJ, Lucas TG, Martins E, Gaspar A, Bandeira A, Nogueira C, Brandão O, Rocha H, Vilarinho L, Gomes CM.

    08/22/2020
    the two variants of ETFDH gene identified probably underlie the pathogenesis of Glutaric acidemia type II in this family, and also enlarge ETFDH genotype-phenotype correlations spectrum.

    A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family.
    Ou M, Zhu L, Zhang Y, Zhang Y, Zhou J, Zhang Y, Chen X, Yang L, Li T, Su X, Hu Q, Wang W., Free PMC Article

    07/18/2020
    Low tumor expression of ETFDH was associated with a poorer overall survival in patients with hepatocellular carcinoma.

    Expression and significance of ETFDH in hepatocellular carcinoma.
    Wu Y, Zhang X, Shen R, Huang J, Lu X, Zheng G, Chen X.

    05/2/2020
    A mutation is the most common EFTDH mutation in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency and is most prevalent in China and South-East Asia where its epidemiology correlates with the distribution and migration patterns of the southern Min population in Southern China and neighbouring countries

    Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations.
    Chen W, Zhang Y, Ni Y, Cai S, Zheng X, Mastaglia FL, Wu J., Free PMC Article

    03/21/2020
    Mutations of the ETFDH gene probably underlie the pathogenesis of lipid storage myopathy in this family

    [Analysis of ETFDH gene variation in a Chinese family affected with lipid storage myopathy].
    Xia Y, Kong X.

    11/2/2019
    Multiple acyl-CoA dehydrogenase deficiency is cause by electron transfer flavoprotein ubiquinone oxidoreductase mutation at heterozygotes with c.1354A>G (p.Arg452Gly) and exon 7-8 deletion for Patient 1, and with c.831+3A>C and exon 1-7 deletion for Patient 2.

    Clinical Features of Multiple Acyl-CoA Dehydrogenase Deficiency With ETFDH Variants in the First Korean Cases.
    Kim YJ, Ko JM, Song J, Lee KA., Free PMC Article

    02/23/2019
    This case report extends the spectrum of ETFDH mutations in multiple acyl-CoA dehydrogenase deficiency (MADD), providing further evidence that patients presenting at least one missense mutation in the FAD-binding domain may respond to either carnitine or riboflavin treatment, due to the recovery of some enzymatic activity.

    Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Missaglia S, Tavian D, Moro L, Angelini C., Free PMC Article

    02/2/2019
    Neurite shortening and impairment in neurite growth was caused by a mutation in ETFDH.

    Neurite growth could be impaired by ETFDH mutation but restored by mitochondrial cofactors.
    Liang WC, Lin YF, Liu TY, Chang SC, Chen BH, Nishino I, Jong YJ.

    09/16/2017
    This study identified three novel compound heterozygous mutations of ETFDH gene in patients with late-onset multiple acyl-CoA dehydrogenase deficiency, and discussed the significant clinical heterogeneity among patients with similar genotype.

    Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.
    Fu HX, Liu XY, Wang ZQ, Jin M, Wang DN, He JJ, Lin MT, Wang N.

    01/28/2017
    ETFDH mutation is the causative gene in patients with adult-onset multiple acyl-CoA dehydrogenase deficiency with severe sensory neuropathy.

    Severe sensory neuropathy in patients with adult-onset multiple acyl-CoA dehydrogenase deficiency.
    Wang Z, Hong D, Zhang W, Li W, Shi X, Zhao D, Yang X, Lv H, Yuan Y.

    12/17/2016
    Mtation c.250G>A and mutation c.353G>T in the ETFDH gene are associate with multiple aeyl-CoA dehydrogenase deficiency with severe fatty liver.

    [Clinical features and gene mutations in a patient with multiple aeyl-CoA dehydrogenase deficiency with severe fatty liver].
    Dai D, Wen F, Zhou S, Chen S.

    07/2/2016
    identified 61 ETFDH mutations, including 31 novel mutations, which were widely distributed within the coding sequence

    Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.
    Xi J, Wen B, Lin J, Zhu W, Luo S, Zhao C, Li D, Lin P, Lu J, Yan C.

    02/21/2015
    Mutations in SLC22A5 and ETFDH are associated with riboflavin responsive-multiple acyl-CoA dehydrogenase deficiency.

    [Mutation analysis for a family affected with riboflavin responsive-multiple acyl-CoA dehydrogenase deficiency].
    Lu J, Ji L.

    10/11/2014
    Results show that a predicted benign ETFDH missense variationc.158A>G in exon 2 causes exon skipping and degradation of ETFDH protein in patient samples.

    The ETFDH c.158A>G variation disrupts the balanced interplay of ESE- and ESS-binding proteins thereby causing missplicing and multiple Acyl-CoA dehydrogenation deficiency.
    Olsen RK, Brøner S, Sabaratnam R, Doktor TK, Andersen HS, Bruun GH, Gahrn B, Stenbroen V, Olpin SE, Dobbie A, Gregersen N, Andresen BS.

    08/9/2014
    Case Report: ETF dehydrogenase mutations resulting in mild glutaric aciduria type II and complex II-III deficiency in liver and muscle.

    Novel ETF dehydrogenase mutations in a patient with mild glutaric aciduria type II and complex II-III deficiency in liver and muscle.
    Wolfe LA, He M, Vockley J, Payne N, Rhead W, Hoppel C, Spector E, Gernert K, Gibson KM., Free PMC Article

    04/12/2014
    folding defects in the variant ETF-QO proteins and multiple acyl-CoA dehydrogenation deficiency

    Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency.
    Cornelius N, Frerman FE, Corydon TJ, Palmfeldt J, Bross P, Gregersen N, Olsen RK.

    06/29/2013
    a significant reduced expression of ETFDH was identified in the muscle of ETFDH-deficient patients; ETFDH deficiency is a major cause of riboflavin-responsive MADD in southern China, and c.250G>A is an important mutation

    Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A.
    Wang ZQ, Chen XJ, Murong SX, Wang N, Wu ZY.

    09/24/2011
    High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy

    High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy.
    Lan MY, Fu MH, Liu YF, Huang CC, Chang YY, Liu JS, Peng CH, Chen SS.

    02/26/2011
    3 known (c.250G>A, c380T>A, c.524G>T) and 1 novel (c.1831G>A) ETFDH mutation were detected by high resolution melting analysis. The carrier frequency of the hotspot mutation, c.250G>A, in the Taiwanese population was found to be 1:125.

    High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Er TK, Liang WC, Chang JG, Jong YJ.

    08/2/2010
    firstprevious page of 2 nextlast